|Day Low/High||143.90 / 146.93|
|52 Wk Low/High||94.59 / 145.50|
Cramer says these red-hot and hopelessly overvalued IPOs are signs people are too bullish. Here's your game plan for next week.
Stocks rise Thursday on a strong U.S. retail sales report and mostly better-than-expected earnings.
Danaher, Honeywell, Schlumberger and an earnings parade moved the markets today. TheStreet's Jim Cramer breaks down what it all means for investors.
Jim Cramer takes a closer look at Kraft Heinz, PepsiCo, Marvell Technology, General Mills, Funko, Signet Jewelers, Abiomed and more.
Jim and Zev discuss earnings season so far, Honeywell's impressive results, Danaher, our financials, and Nvidia.
We like the flexibility we have with our war chest of capital and look forward to our hunt for the next Danaher.
Where are you putting your PINS in this market? Jim Cramer is breaking down the latest Wall Street action live.
Danaher reports first-quarter earnings that beat analysts' estimates though revises forward guidance on costs related to acquisition of GE's biopharma business.
Negative political pressure is being felt in an overbearing way on the entire healthcare sector.
U.S. stock futures fall as investors adopt a cautious ahead of trading Thursday; Schlumberger and Honeywell report earnings; Pinterest's IPO is priced at $19 a share; JPMorgan Chase makes c-suite changes.
WASHINGTON, April 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019.
We are ringing the register this afternoon and declaring victory on DHR ahead of earnings.
Jim discusses Abbott Laboratories' earnings release, his view of the Apple-Qualcomm settlement as it relates to the 5G cycle, several upcoming earnings reports, Anadarko Petroleum, UnitedHealth and much more!
UnitedHealth Group and Johnson & Johnson report Tuesday, Abbott Labs on Wednesday, and Honeywell, Schlumberger and Danaher on Thursday.
Jim Cramer says this positive start will be hard to sustain this earnings season. He's got your game plan for next week.
Monday was a demonstration of pretty much everything analysts can throw at stocks to get you out while the getting is still good.
Time could run out before Larry Culp can complete his turnaround plan at GE.
General Electric shares fell the most in a month Monday after one of Wall Street's most influential analysts lowered his rating for the struggling industrial giant and cut the group's price target.
GE stock hasn't solved its free cash flow conundrum, and might not for some time, says a key analyst.
Markets move higher as investors shrug off slowing growth to focus on U.S.-China Trade Deal hopes.
We have long cautioned on our member-only conference calls about the flush of IPOs coming to market and its impact to stocks.
Stocks finish week sharply lower on worries over global economic growth slowing after earlier surging on Fed's more accommodating stance.
We are encouraged with CVS Health's plans to fix what has hurt the company and we reiterate that the stock is still inexpensive.
We will lighten up on this position and use our big gains as a source of capital.
On the 14th anniversary for 'Mad Money', Jim Cramer talks about how to balance owning index funds and individual stocks.
General Electric issued fresh 2019 earnings guidance Thursday that missed analysts' forecast, sending shares in the troubled industrial giant sharply lower in pre-market trading.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.